IART · Integra Lifesciences
AI read · Bad for IART
The AI's read
The flood disrupted product availability, and Tissue Reconstruction sales did not grow as expected. Integra now needs to restore supply and sales. Strong cash flow, higher profit per share, and refinancing give the company more room, but do not erase the weaker outlook.